BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11129920)

  • 21. Clinical management of portopulmonary hypertension.
    Tam NL; He XS
    Hepatobiliary Pancreat Dis Int; 2007 Oct; 6(5):464-9. PubMed ID: 17897906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients.
    Khan TA; Schnickel G; Ross D; Bastani S; Laks H; Esmailian F; Marelli D; Beygui R; Shemin R; Watson L; Vartapetian I; Ardehali A
    J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1417-24. PubMed ID: 19931670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atrial septostomy improves survival in select patients with pulmonary hypertension.
    Law MA; Grifka RG; Mullins CE; Nihill MR
    Am Heart J; 2007 May; 153(5):779-84. PubMed ID: 17452153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary pulmonary hypertension: modes of diagnosis and aggressive treatment with vasodilators.
    Rich S
    Mt Sinai J Med; 1990 Mar; 57(2):63-74. PubMed ID: 2195321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Arterial switch operation in older infants with severe pulmonary hypertension].
    Wu QY; Shen XD; Yang XB; Li SJ; Yan J; Guo Y; Wang X; Chen X; He XL
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(6):478-81. PubMed ID: 12887761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pulmonary arterial hypertension].
    Jaïs X; Sitbon O; Savale L; Montani D; Humbert M; Simonneau G
    Rev Prat; 2008 Nov; 58(18):1997-2010. PubMed ID: 19143271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High levels of nitric oxide in individuals with pulmonary hypertension receiving epoprostenol therapy.
    Ozkan M; Dweik RA; Laskowski D; Arroliga AC; Erzurum SC
    Lung; 2001; 179(4):233-43. PubMed ID: 11891614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of pulmonary artery banding in the setting of ventricular septal defects and severely elevated pulmonary vascular resistance.
    Khan SA; Gelb BD; Nguyen KH
    Congenit Heart Dis; 2006 Sep; 1(5):244-50. PubMed ID: 18377533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular pathophysiology and therapy of pulmonary hypertension.
    Olschewski H; Rose F; Grünig E; Ghofrani HA; Walmrath D; Schulz R; Schermuly R; Grimminger F; Seeger W
    J Lab Clin Med; 2001 Dec; 138(6):367-77. PubMed ID: 11753283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis and treatment of pulmonary hypertension.
    Nauser TD; Stites SW
    Am Fam Physician; 2001 May; 63(9):1789-98. PubMed ID: 11352291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pulmonary arterial hypertension in adults with congenital heart disease].
    Bouzas B; Gatzoulis MA
    Rev Esp Cardiol; 2005 May; 58(5):465-9. PubMed ID: 15899189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current management of primary pulmonary hypertension.
    Klings ES; Farber HW
    Drugs; 2001; 61(13):1945-56. PubMed ID: 11708765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term outcome of patients operated for large ventricular septal defects with increased pulmonary vascular resistance.
    Kannan BR; Sivasankaran S; Tharakan JA; Titus T; Ajith Kumar VK; Francis B; Krishnamoorthy KM; Harikrishnan S; Padmakumar R; Nair K
    Indian Heart J; 2003; 55(2):161-6. PubMed ID: 12921332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The response to inhaled nitric oxide in patients with pulmonary artery hypertension is not masked by baseline vasodilator use.
    Krasuski RA; Wang A; Harrison JK; Tapson VF; Bashore TM
    Am Heart J; 2005 Oct; 150(4):725-8. PubMed ID: 16209974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pulmonary hypertension associated with systemic lupus erythematosus].
    Haas C
    Bull Acad Natl Med; 2004; 188(6):985-97; discussion 997. PubMed ID: 15651427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV-related pulmonary hypertension.
    Limsukon A; Saeed AI; Ramasamy V; Nalamati J; Dhuper S
    Mt Sinai J Med; 2006 Nov; 73(7):1037-44. PubMed ID: 17195895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulating the pulmonary circulation: an update.
    Dembinski R; Henzler D; Rossaint R
    Minerva Anestesiol; 2004 Apr; 70(4):239-43. PubMed ID: 15173703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary flow reserve in children with idiopathic pulmonary arterial hypertension: implications for diagnosis and therapy.
    Zimmermann R; Kreuder J; Michel-Behnke I; Voelkel NF; Schranz D
    Eur J Med Res; 2006 May; 11(5):208-13. PubMed ID: 16723295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary pulmonary hypertension. An analysis of 28 cases and a review of the literature.
    Hughes JD; Rubin LJ
    Medicine (Baltimore); 1986 Jan; 65(1):56-72. PubMed ID: 2867454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pulmonary arterial hypertension. Part I: pathobiologic, pathophysiologic, clinical and diagnostic aspects].
    Palazzini M; Manes A; Negro L; Marinelli A; Leci E; Gambetti S; Bachetti C; Beciani E; Conficoni E; Branzi A; Galiè N
    G Ital Cardiol (Rome); 2009 May; 10(5):271-300. PubMed ID: 19537440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.